Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
3.465
-0.045 (-1.28%)
Mar 31, 2025, 1:41 PM EDT - Market open

Third Harmonic Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
22.3719.9913.33.261.17
Research & Development
36.523.9624.4115.759.95
Operating Expenses
58.8743.9537.711911.12
Operating Income
-58.87-43.95-37.71-19-11.12
Interest Expense
---0--
Interest & Investment Income
13.4113.112.560.01-
Other Non Operating Income (Expenses)
-0.010.02---
EBT Excluding Unusual Items
-45.47-30.82-35.16-19-11.12
Other Unusual Items
----10.61-1.69
Pretax Income
-45.47-30.82-35.16-29.61-12.81
Net Income
-45.47-30.82-35.16-29.61-12.81
Net Income to Common
-45.47-30.82-35.16-29.61-12.81
Shares Outstanding (Basic)
42401444
Shares Outstanding (Diluted)
42401444
Shares Change (YoY)
5.26%176.22%254.97%10.23%-
EPS (Basic)
-1.09-0.78-2.45-7.32-3.49
EPS (Diluted)
-1.09-0.78-2.45-7.32-3.49
Free Cash Flow
-34.51-20.59-34.95-15.75-9.19
Free Cash Flow Per Share
-0.83-0.52-2.44-3.89-2.50
EBITDA
-58.82-43.92-37.71--
D&A For EBITDA
0.050.040--
EBIT
-58.87-43.95-37.71-19-11.12
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q